Petrelintide clinical trials
Also written ZP8396 and RO7895515.
How each study uses petrelintide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the petrelintide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2026 (5)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test petrelintide.
- Apr 2027Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic FunctionPhase 1 · Zealand Pharma
- Nov 2027A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or OverweightPhase 2 · Hoffmann-La Roche
Studies
Open first, then newest update. How each study uses petrelintide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular DiseaseRecruitingPhase 3Hoffmann-La RocheNCT07843472Written as Petrelintide
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 DiabetesRecruitingPhase 3Hoffmann-La RocheNCT07843485Written as Petrelintide
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or ObesityRecruitingPhase 3Hoffmann-La RocheNCT07843498Written as Petrelintide
- A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or OverweightNot yet recruitingPhase 2Hoffmann-La RocheNCT07589686Written as Petrelintide
- Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic FunctionRecruitingPhase 1Zealand PharmaNCT07682818Written as Petrelintide
- A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy ParticipantsCompletedPhase 1Zealand PharmaNCT05613387Written as ZP8396
- Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)CompletedPhase 2Zealand PharmaNCT06926842Written as Petrelintide
- Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product ConcentrationsCompletedPhase 1Zealand PharmaNCT07338214Written as Petrelintide
- Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbiditiesCompletedPhase 2Zealand PharmaNCT06662539Written as Petrelintide
- Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal FunctionCompletedPhase 1Zealand PharmaNCT07076030Written as Petrelintide
- A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial ParticipantsCompletedPhase 1Zealand PharmaNCT05096598Written as ZP8396
Codes
What other systems call petrelintide · ClinicalTrials.gg INT016298
- UNII (FDA) D78KBY7BRUPETRELINTIDEOne source FDA
- NCI Thesaurus C203201PetrelintideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | D78KBY7BRU | PETRELINTIDE | One source FDA |
| NCI Thesaurus | C203201 | Petrelintide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.